Literature DB >> 1379984

Role of the mononuclear phagocyte as an antigen-presenting cell for human gamma delta T cells activated by live Mycobacterium tuberculosis.

W H Boom1, K A Chervenak, M A Mincek, J J Ellner.   

Abstract

gamma delta T cells, both human and murine, have been found to be highly responsive to mycobacterial antigens. However, the role and function of gamma delta T cells in the immune response to Mycobacterium tuberculosis remain largely unknown. In earlier studies, we demonstrated that monocytes infected with live M. tuberculosis were particularly effective inducers of human peripheral blood gamma delta T cells. The present studies were performed to further characterize the interaction between human mononuclear phagocytes, gamma delta T cells, and live M. tuberculosis, in comparison with CD4+ T cells. First, we found that resting gamma delta T cells expanded in vitro by live M. tuberculosis were specific for M. tuberculosis, and that heat killing and washing the mycobacteria removed the antigen(s) for gamma delta T cells. In contrast, the heat-killed mycobacteria retained significant antigenicity for CD4+ T cells. Second, live M. tuberculosis-expanded gamma delta T cells from healthy tuberculin-positive donors did not respond significantly to the antigens in M. tuberculosis culture filtrate, including the 65- and 71-kDa mycobacterial heat shock proteins. Third, the activation of gamma delta T cells by live mycobacteria was dependent on antigen-presenting cells, and mononuclear phagocytes were found to be very efficient antigen-presenting cells both for resting peripheral blood gamma delta T cells and for activated expanded gamma delta T cells. The mononuclear phagocyte carried the necessary costimulatory factors necessary for gamma delta T-cell proliferation. Fourth, the antigen repertoire and HLA requirements for CD4+ memory T cells and those for gamma delta T cells appear to be quite distinct from each other. CD4+ T cells recognized both soluble protein antigens and whole organisms in a class II major histocompatibility complex-restricted manner, whereas gamma delta T cells appeared to recognize only constituents associated with the whole organism and were not restricted by class I or class II major histocompatibility complex molecules. Finally, the assay system described to expand and purify responding CD4+ and gamma delta T cells after stimulation with live M. tuberculosis represented a simple approach to the direct comparison of these two T-cell populations in the interaction with mononuclear phagocytes infected with M. tuberculosis. Such studies provide insight not only into the relative roles of human CD4+ and gamma delta T cells in the human immune response to intracellular bacterial pathogens such as M. tuberculosis but also into the basic biologic role of human gamma delta T cells in antimicrobial immunity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1379984      PMCID: PMC257348          DOI: 10.1128/iai.60.9.3480-3488.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  Stimulation of a major subset of lymphocytes expressing T cell receptor gamma delta by an antigen derived from Mycobacterium tuberculosis.

Authors:  R L O'Brien; M P Happ; A Dallas; E Palmer; R Kubo; W K Born
Journal:  Cell       Date:  1989-05-19       Impact factor: 41.582

2.  Evidence for involvement of the gamma, delta T cell antigen receptor in cytotoxicity mediated by human alloantigen-specific T cell clones.

Authors:  A Rivas; J Koide; M L Cleary; E G Engleman
Journal:  J Immunol       Date:  1989-03-15       Impact factor: 5.422

3.  Preliminary characterization of accessory cells in the nonadherent fraction of human blood mononuclear cells.

Authors:  E A Rich; J J Ellner
Journal:  Cell Immunol       Date:  1986-12       Impact factor: 4.868

Review 4.  The role of cell-mediated immunity in bacterial infections.

Authors:  H Hahn; S H Kaufmann
Journal:  Rev Infect Dis       Date:  1981 Nov-Dec

5.  Lymphocytes bearing antigen-specific gamma delta T-cell receptors accumulate in human infectious disease lesions.

Authors:  R L Modlin; C Pirmez; F M Hofman; V Torigian; K Uyemura; T H Rea; B R Bloom; M B Brenner
Journal:  Nature       Date:  1989-06-15       Impact factor: 49.962

6.  Early appearing gamma/delta-bearing T cells during infection with Calmétte Guérin bacillus.

Authors:  T Inoue; Y Yoshikai; G Matsuzaki; K Nomoto
Journal:  J Immunol       Date:  1991-04-15       Impact factor: 5.422

7.  Structure and mapping of antigenic domains of protein antigen b, a 38,000-molecular-weight protein of Mycobacterium tuberculosis.

Authors:  A B Andersen; E B Hansen
Journal:  Infect Immun       Date:  1989-08       Impact factor: 3.441

8.  Signal transduction of gamma/delta T cell antigen receptor with a novel mitogenic anti-delta antibody.

Authors:  Y J Wu; W T Tian; R M Snider; C Rittershaus; P Rogers; L LaManna; S H Ip
Journal:  J Immunol       Date:  1988-09-01       Impact factor: 5.422

9.  Increase of T-cell receptor gamma/delta-bearing T cells in cord blood of newborn babies obtained by in vitro stimulation with mycobacterial cord factor.

Authors:  I Tsuyuguchi; H Kawasumi; C Ueta; I Yano; S Kishimoto
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

10.  Resident pulmonary lymphocytes expressing the gamma/delta T-cell receptor.

Authors:  A Augustin; R T Kubo; G K Sim
Journal:  Nature       Date:  1989-07-20       Impact factor: 49.962

View more
  26 in total

1.  The expansion of human gammadelta T cells in response to Daudi cells requires the participation of CD4+ T cells.

Authors:  J D Fayen; M L Tykocinski
Journal:  Immunology       Date:  1999-06       Impact factor: 7.397

2.  Granule-dependent cytolysis of Mycobacterium tuberculosis-infected macrophages by human gammadelta+ T cells has no effect on intracellular mycobacterial viability.

Authors:  J S Passmore; R H Glashoff; P T Lukey; S R Ress
Journal:  Clin Exp Immunol       Date:  2001-10       Impact factor: 4.330

3.  Increase of heat-shock protein and induction of gamma/delta T cells in peritoneal exudate of mice after injection of live Fusobacterium nucleatum.

Authors:  K Saito; H Katsuragi; M Mikami; C Kato; M Miyamaru; K Nagaso
Journal:  Immunology       Date:  1997-02       Impact factor: 7.397

4.  Dynamic changes in circulating and antigen-responsive T-cell subpopulations post-Mycobacterium bovis infection in cattle.

Authors:  J M Pollock; D A Pollock; D G Campbell; R M Girvin; A D Crockard; S D Neill; D P Mackie
Journal:  Immunology       Date:  1996-02       Impact factor: 7.397

Review 5.  Immunopathology of tuberculosis: roles of macrophages and monocytes.

Authors:  M J Fenton; M W Vermeulen
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

6.  Gammadelta+ and CD4+ alphabeta+ human T cell subset responses upon stimulation with various Mycobacterium tuberculosis soluble extracts.

Authors:  G Batoni; S Esin; R A Harris; G Källenius; S B Svenson; R Andersson; M Campa; H Wigzell
Journal:  Clin Exp Immunol       Date:  1998-04       Impact factor: 4.330

Review 7.  Immunology of Mycobacterium tuberculosis Infections.

Authors:  Jonathan Kevin Sia; Jyothi Rengarajan
Journal:  Microbiol Spectr       Date:  2019-07

8.  Modulation of Mycobacterium bovis-specific responses of bovine peripheral blood mononuclear cells by 1,25-dihydroxyvitamin D(3).

Authors:  W R Waters; B J Nonnecke; T E Rahner; M V Palmer; D L Whipple; R L Horst
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

9.  Characterization of a 10- to 14-kilodalton protease-sensitive Mycobacterium tuberculosis H37Ra antigen that stimulates human gamma delta T cells.

Authors:  W H Boom; K N Balaji; R Nayak; K Tsukaguchi; K A Chervenak
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

10.  Infection of Mycobacterium bovis bacillus Calmette-Guérin in antibody-mediated gamma delta T-cell-depleted mice.

Authors:  S Nabeshima; K Hiromatsu; G Matsuzaki; A Mukasa; H Takada; S Yoshida; K Nomoto
Journal:  Immunology       Date:  1995-02       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.